Delivery Order SPE2DB20D3101-SPE2DB23FRVE8

Award Date 8/17/23
Potential Completion Date 8/18/23
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of REYVOW 100 MG TABLET UD 8S, a prescription medication, to the Defense Logistics Agency (DLA). The contract, valued at $3,974.21, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance ending on January 11, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of Reyvow 50 mg Tablet UD 8s to the Defense Logistics Agency (DLA). The $1,226.31 firm-fixed-price delivery order was awarded on February 25, 2022 to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,452.04 firm fixed-price delivery order covers the supply of REYVOW 100 MG TABLET UD 8S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,226.28, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S medical products, with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,226.31 firm fixed-price delivery order is for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has a completion date of July 8, 2022 and was awarded on July 7, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,413.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a period of performance through November 14, 2024. The contract is a firm fixed-price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,279.23 and an ultimate completion date of December 29, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,101.32, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of March 11, 2025 and is not designated as a set-aside. The contract provides for the delivery of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product, to support federal government...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, with a ceiling value of $1,467.90, is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of June 9, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,226.28, is for the delivery of REYVOW 50 MG TABLET UD 8S medical supplies. The contract has a firm fixed price and a completion date of November 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRVE8
    Delivery Order

This federal contract award is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,226.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc.

The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 2/27/25, 9:47 AM